Search results for "TOP"

showing 10 items of 17685 documents

Impacto de la variación en el número de copias y del estado de metilación de genes supresores de tumor en las vías de progresión del meningioma

2015

El meningioma es el tumor del sistema nervioso central más frecuente en la edad adulta, con una incidencia superior al 30% y una evidente predominancia femenina. La sintomatología deriva fundamentalmente de la localización del tumor, que crece desde las células de la cubierta aracnoidea. El tratamiento es principalmente quirúrgico, y su radicalidad se relaciona clásicamente con la aparición de recidivas tumorales, que es la principal complicación que sufren los afectados. Macroscópicamente, son tumores habitualmente bien delimitados y encapsulados, de crecimiento lento, y microscópicamente la OMS los clasifica en 16 subtipos histológicos. Son tumores positivos para vimentina y EMA, y en men…

:CIENCIAS MÉDICAS ::Patología::Neuropatología [UNESCO]:CIENCIAS DE LA VIDA::Biología humana ::Genética humana [UNESCO]:CIENCIAS DE LA VIDA::Biología celular::Citogenética [UNESCO]citogenéticaUNESCO::CIENCIAS DE LA VIDA::Biología celular::Cultivo celularFFPEUNESCO::CIENCIAS MÉDICAS ::Patología::NeuropatologíameningiomaUNESCO::CIENCIAS DE LA VIDA::Biología celular::CitogenéticaMLPAepigenética:CIENCIAS DE LA VIDA::Biología celular::Cultivo celular [UNESCO]genes supresores de tumorUNESCO::CIENCIAS MÉDICAS ::Patología::HistopatologíaUNESCO::CIENCIAS DE LA VIDA::Biología humana ::Genética humana:CIENCIAS MÉDICAS ::Patología::Histopatología [UNESCO]
researchProduct

Self-Organized Linguistic Systems: From traditional AI to bottom-up generative processes

2018

Este trabajo busca explorar el potencial de los procesos generativos bottom-up en el contexto de la producción conlang, con el objetivo de describir las bases de un nuevo campo de investigación: los Sistemas Lingüísticos Autoorganizados o SOLS, específicamente bajo la perspectiva doble de sistemas autoorganizados y lenguajes construidos. El enfoque SOLS proporciona un marco para la creación de lenguajes artificiales autogenerados y puede servir como punto de partida para el desarrollo de lenguajes dependientes del contexto o específicos del dominio. Reconoce que el desarrollo de conlangs puede ocurrir en sociedades artificiales de agentes simples, como resultado de interacciones sociales en…

:CIENCIAS TECNOLÓGICAS [UNESCO]Sociology and Political ScienceKnowledge representation and reasoningComputer scienceContext (language use)02 engineering and technologyDevelopment050105 experimental psychology0202 electrical engineering electronic engineering information engineeringemergence0501 psychology and cognitive sciencesBusiness and International ManagementAdaptation (computer science)UNESCO::LÓGICAconlangsconstructed languages05 social sciencesTop-down and bottom-up designUNESCO::CIENCIAS TECNOLÓGICASartificial intelligenceagent-based modellingUNESCO::LINGÜÍSTICAself-organizationLinguisticsConstructed languageSocial dynamics:LINGÜÍSTICA [UNESCO]Embodied cognition020201 artificial intelligence & image processing:LÓGICA [UNESCO]Generative grammarFutures
researchProduct

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycl…

2009

Background The prevalence of and risk factors for central nervous system recurrence in patients with acute promyelocytic leukemia are not well established and remain a controversial matter. Design and Methods Between 1996 and 2005, 739 patients with newly diagnosed acute promyelocytic leukemia enrolled in two consecutive trials (PETHEMA LPA96 and LPA99) received induction therapy-with all-trans retinoic acid and idarubicin. Consolidation therapy comprised three courses of anthracycline monochemotherapy (LPA96), with all-trans retinoic acid and reinforced doses of idarubicin in patients with an intermediate or high risk of relapse (LPA99). Central nervous system prophylaxis was not given. Re…

:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Idarubicin [Medical Subject Headings]:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Male:Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings]idarubicinGastroenterology:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Central Nervous System NeoplasmsLeukemia Promyelocytic AcuteRecurrenceRisk FactorsCumulative incidenceAntibiotics AntineoplasticHematologyMiddle Agedall-trans retinoic acidLeukemiamedicine.anatomical_structure:Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings]Femalemedicine.drugAcute promyelocytic leukemiaAdultcentral nervous system relapsemedicine.medical_specialty:Diseases::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia Myeloid::Leukemia Myeloid Acute [Medical Subject Headings]AnthracyclineAdolescentCentral nervous system:Check Tags::Male [Medical Subject Headings]TretinoinNeoplasias del sistema nervioso centralCentral nervous system diseaseTretinoinInternal medicine:Named Groups::Persons::Age Groups::Adult [Medical Subject Headings]medicineIdarubicinHumans:Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings]Letters to the Editor:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Acyclic::Alkenes::Polyenes::Carotenoids::Retinoids [Medical Subject Headings]Leucemia promielocítica agudaAgedAntibióticos antineoplásicosbusiness.industryprognostic factors:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antibiotics Antineoplastic [Medical Subject Headings]acute promyelocytic leukemiamedicine.diseaseSurgery:Diseases::Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms [Medical Subject Headings]:Check Tags::Female [Medical Subject Headings]businessIdarubicin
researchProduct

Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies

2020

Alpha-lipoic acid (ALA) is a natural short-chain fatty acid that has attracted great attention in recent years as an antioxidant molecule. However, some concerns have been recently raised regarding its safety profile. To address the issue, we aimed to assess ALA safety profile through a systematic review of the literature and a meta-analysis of the available randomized placebo-controlled clinical studies. The literature search included EMBASE, PubMed Medline, SCOPUS, Google Scholar, and ISI Web of Science by Clarivate databases up to 15th August 2020. Data were pooled from 71 clinical studies, comprising 155 treatment arms, which included 4749 subjects with 2558 subjects treated with ALA an…

:Chemicals and Drugs::Pharmaceutical Preparations::Placebos [Medical Subject Headings]Physiologyα -lipoic acid ; thioctic acid ; dietary supplement ; safety ; meta-analysisClinical BiochemistryDisease030204 cardiovascular system & hematologyBiochemistrymeta-analysi:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antioxidants [Medical Subject Headings]Dietary supplementchemistry.chemical_compound0302 clinical medicinethioctic aciddietary supplement meta-analysis safety thioctic acid α-lipoic acid:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Clinical Trials as Topic::Controlled Clinical Trials as Topic::Randomized Controlled Trials as Topic [Medical Subject Headings]α-lipoic acidLipoic acidSafety profile:Publication Type::Study Characteristics::Meta-Analysis [Medical Subject Headings]Suplementos dietéticosMeta-analysis:Technology and Food and Beverages::Food and Beverages::Food::Dietary Supplements [Medical Subject Headings]SafetysafetyAlpha-lipoic acidmedicine.medical_specialtyMEDLINEÁcido tióctico030209 endocrinology & metabolismPlacebo:Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Thiophenes::Thioctic Acid [Medical Subject Headings]Article:Health Care::Environment and Public Health::Public Health::Accidents::Accident Prevention::Safety [Medical Subject Headings]03 medical and health sciencesα‐lipoic acidThioctic acidInternal medicineDiabetes mellitusmedicineMetaanálisisAdverse effectSeguridad:Diseases::Cardiovascular Diseases [Medical Subject Headings]Molecular Biology:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Volatile [Medical Subject Headings]business.industryRevisión sistemáticalcsh:RM1-950Cell Biologymedicine.disease:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Habits::Food Habits::Smoking [Medical Subject Headings]meta-analysisMeta-analysislcsh:Therapeutics. Pharmacologychemistry:Diseases::Nervous System Diseases [Medical Subject Headings]dietary supplementMeta‐analysisbusinessAntioxidants
researchProduct

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

2007

Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…

:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Veterinary medicine:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Streptomycin [Medical Subject Headings]:Phenomena and Processes::Microbiological Phenomena::Drug Resistance Microbial [Medical Subject Headings]DiseaseGlobal Health:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Health Care::Population Characteristics::Health::World Health [Medical Subject Headings]Terminología como AsuntoBrucellosi:Organisms::Eukaryota::Animals [Medical Subject Headings]:Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings]Policy ForumMedicine in Developing CountriesGentamicinasDrug Resistance MicrobialBrucelosisAdhesión a DirectrizGeneral MedicineHumanosDrug CombinationsAntibacterianosDoxycyclineStreptomycinEstreptomicinaMedicine:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds with 4 or More Rings::Rifamycins::Rifampin [Medical Subject Headings]Drug Therapy CombinationGuideline AdherenceRifampinFluoroquinolonesSalud Mundialmedicine.medical_specialtyEfficacyResultado del TratamientoInvestigación BiomédicaRecurrenciaTherapeuticsWorld Health OrganizationMicrobiologyAntibiotic resistanceTerminology as Topic:Disciplines and Occupations::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]HumansMedical journalIntensive care medicineDeveloping Countries:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Trimethoprim::Trimethoprim-Sulfamethoxazole Combination [Medical Subject Headings]medicine.diseaseCotrimoxazoleAnimalesQuimioterapia:Humanities::Humanities::History::History Modern 1601-::History 21st Century [Medical Subject Headings]GentamicinsBrucel·losiBiomedical ResearchCommunicable diseases:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 2-Ring::Quinolines::Quinolones::Fluoroquinolones [Medical Subject Headings]Human diseaseRecurrence:Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings]:Information Science::Information Science::Communication::Language::Linguistics::Terminology as Topic [Medical Subject Headings]biologyIraqi patientsRMetaanalysis:Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Brucellosis [Medical Subject Headings]Historia del Siglo XXIAnti-Bacterial AgentsCombinación Trimetoprim-SulfametoxazolTreatment OutcomeInfectious Diseases:Disciplines and Occupations::Natural Science Disciplines::Science::Research::Biomedical Research [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Tetracyclines::Doxycycline [Medical Subject Headings]Fluoroquinolonas:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicins [Medical Subject Headings]Países en Desarrollo:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy Combination [Medical Subject Headings]BrucellaHistory 21st CenturyBrucellosisWorld healthTrimethoprim Sulfamethoxazole Drug CombinationmedicineAnimals:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Resistencia a Medicamentosbusiness.industryOrganización Mundial de la SaludBrucellosisMalalties infecciosesTerapèuticabiology.organism_classificationCombinación de MedicamentosDoxiciclinaTherapybusinessBrucella melitensisPLoS Medicine
researchProduct

MUC, instrucciones de instalación y manual de uso

2019

Instrucciones de instalación y breve manual de uso de la aplicación MUC: Medida de Umbrales Cromáticos. Installation instructions and short user guide for MUC, a stand-alone application for the measurement of chromatic thresholds.

:FÍSICA [UNESCO]discromatopsiaumbrales cromáticosUNESCO::FÍSICA
researchProduct

Electromagnetic interactions of light hadrons in covariant chiral perturbation theory

2017

Las interacciones entre hadrones ligeros y campos de fotones son importantes para el estudio de la estructura de la materia y de la interacción fuerte. Sus propiedades fundamentales son descritas por la cromodinámica quántica (QCD). A energı́as elevadas, esta teorı́a ya ha sido bien comprobada con métodos perturbativos que tienen los quarks y gluones como grados de libertad. Sin embargo, a bajas energı́as, QCD es no-perturbativa y quedan muchos detalles por entender. Estas on precisamente las energı́as necesarias para describir interacciones entre hadrones a distancias superiores a su tamaño. Procesos que involucran interacciones con hadrones han sido extensamente estudiados a lo largo de l…

:FÍSICA::Física atómica y nuclear [UNESCO]UNESCO::FÍSICA::Física atómica y nuclearTeoría quiral de perturbaciones con barionesResonancia deltaPolarizabilidadesHiperonesFactores de forma electromagnéticosFotoproducción de pionesMomento dipolar eléctricoDispersión Compton
researchProduct

Measurement of the top quark pair production cross section in proton-proton collisions at center-of-mass energies of 7 TeV in final states with a tau…

2014

El Modelo Estándar (SM) de la Física de Partículas es una teoría cuántica de campos desarrollada en los años 60 para explicar el comportamiento de las partículas elementales y las fuerzas fundamentales que gobiernan sus interacciones. El Modelo Estándar ha sido comprobado experimentalmente, ha pronosticado con gran precisión una amplia variedad de fenómenos y ha explicado con éxito numerosos resultados experimentales. Para la exploración de fenómenos de nueva Física, la Organización Europea para la Investigación Nuclear (CERN) ha construido un acelerador y colisionador de partículas, el Gran Colisionador de Hadrones, LHC. El acelerador, los detectores y la infraestructura informática necesa…

:FÍSICA::Física de altas energías [UNESCO]cross section:FÍSICA [UNESCO]UNESCO::FÍSICAUNESCO::FÍSICA::Física de altas energíastau leptontop quark
researchProduct

Overview of the JET preparation for deuterium-tritium operation with the ITER like-wall

2019

Documento escrito por un elevado número de autores/as, sólo se referencia el/la que aparece en primer lugar y los/as autores/as pertenecientes a la UC3M For the past several years, the JET scientific programme (Pamela et al 2007 Fusion Eng. Des. 82 590) has been engaged in a multi-campaign effort, including experiments in D, H and T, leading up to 2020 and the first experiments with 50%/50% D–T mixtures since 1997 and the first ever D–T plasmas with the ITER mix of plasma-facing component materials. For this purpose, a concerted physics and technology programme was launched with a view to prepare the D–T campaign (DTE2). This paper addresses the key elements developed by the JET programme d…

:Física [Ciências exactas e naturais]Nuclear engineeringPLASMASCONFINEMENTfusion power7. Clean energy01 natural sciences010305 fluids & plasmaslaw.inventionlawTRANSPORT EXPERIMENTSFusió nuclearMODESettore FIS/01Jet (fluid)fusion power ; JET ; tritium ; isotopeILW DIVERTORIsotopetritiumPhysicsSettore ING-IND/18 - Fisica dei Reattori NuclearimodeInjectorCondensed Matter PhysicsFusion Plasma and Space PhysicsSettore ING-IND/20 - Misure e Strumentazione Nucleariconfinementperformance[PHYS.PHYS.PHYS-FLU-DYN]Physics [physics]/Physics [physics]/Fluid Dynamics [physics.flu-dyn]Nuclear and High Energy PhysicsTechnology and Engineeringfusion power; JET; tritium; isotopetransport experimentsPlasma (Gasos ionitzats)Tritium114 Physical sciencesFísica FísicaFusion plasma och rymdfysik:Physical sciences [Natural sciences]0103 physical sciencesThermalFusion powerFusiónNeutronddc:530010306 general physicsisotopePhysics Physical sciencesQC717fusion power; isotope; JET; tritiumPlasma (Ionized gases)Spectrometer:Física [Àrees temàtiques de la UPC]FísicaPlasmaFusion powerPERFORMANCEplasmasilw divertorHigh-confinement mode13. Climate actionJetJETEnvironmental scienceNuclear fusion
researchProduct

Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.

2015

Objective: To assess Spanish and Portuguese patients' and physicians' preferences regarding type 2 diabetes mellitus (T2DM) treatments and the monthly willingness to pay (WTP) to gain benefits or avoid side effects. Methods: An observational, multicenter, exploratory study focused on routine clinical practice in Spain and Portugal. Physicians were recruited from multiple hospitals and outpatient clinics, while patients were recruited from eleven centers operating in the public health care system in different autonomous communities in Spain and Portugal. Preferences were measured via a discrete choice experiment by rating multiple T2DM medication attributes. Data were analyzed using the cond…

:Geographicals::Geographic Locations::Europe::Portugal [Medical Subject Headings]cardiovascular riskHbA1cendocrine system diseases:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Hypoglycemia [Medical Subject Headings]:Disciplines and Occupations::Health Occupations::Medicine::Public Health [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Named Groups::Persons::Occupational Groups::Health Personnel::Physicians [Medical Subject Headings]HbA(1c)HbA:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Body Weight::Body Weight Changes::Weight Loss [Medical Subject Headings]:Diseases::Cardiovascular Diseases [Medical Subject Headings]preferences:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]diabetesnutritional and metabolic diseasesPeso corporalweightPérdida de peso:Health Care::Health Care Facilities Manpower and Services::Health Facilities::Ambulatory Care Facilities [Medical Subject Headings]Diabetes mellitus tipo 2:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Signs and Symptoms Digestive::Nausea [Medical Subject Headings]hypoglycemia:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models Statistical::Logistic Models [Medical Subject Headings]:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Body Weight [Medical Subject Headings]:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus Type 2 [Medical Subject Headings]:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents [Medical Subject Headings]Enfermedades cardiovascularesHipoglucemiawillingness to pay:Check Tags [Medical Subject Headings]discrete choice model
researchProduct